Securities Code: 300759
Securities Abbreviation: Kanglong Chemical
Announcement Number: 2026-040
Kanglong Chemical (Beijing) New Drug Technology Co., Ltd. announces the investment and construction of a project for the annual production of 200 tons of pharmaceutical intermediates and APIs. The company and all members of the board guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Risk Warning:
- This project investment is based on the strategic development needs of Kanglong Chemical (Beijing) New Drug Technology Co., Ltd. (hereinafter referred to as "the Company") and the judgment of the industry market outlook. However, there are uncertainties regarding industry development trends, market fluctuations, and the business expansion capabilities of the management team, which may impact future operational effectiveness.
- The project construction involves approvals related to project establishment, land use, environmental protection, planning, and construction, and must obtain approvals from relevant authorities. Therefore, there are risks of delays, changes, suspension, or termination of the project.
- The project investment scale is large, and funding sources, usage arrangements, and construction progress may be affected by macroeconomic factors, fundraising during construction, and changes in credit policies. Investors are advised to be aware of investment risks.